Evidence map›Paper›PMID 28357297›Full record

ReviewMicrobial cell (Graz, Austria)2015

Wanted

Fatimata Sow, Mary Nyonda, Anne-Lise Bienvenu, Stephane Picot

Abstract readReview
In one paragraph

Review in Microbial cell (Graz, Austria), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. The Cross-Species Immunity During AcuteFrontiers in cellular and infection microbiology · 2022
    Article
  3. Review
  4. Pumilacidins from the Octocoral-AssociatedMolecules (Basel, Switzerland) · 2018
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fatimata SowUniversity Claude Bernard Lyon 1, Malaria Research Unit, SMITh, ICBMS, UMR 5246 CNRS-INSA-CPE-UCBL1, 8 avenue Rockefeller, 69373 Lyon cedex 08, France.
Mary NyondaUniversity Claude Bernard Lyon 1, Malaria Research Unit, SMITh, ICBMS, UMR 5246 CNRS-INSA-CPE-UCBL1, 8 avenue Rockefeller, 69373 Lyon cedex 08, France.
Anne-Lise BienvenuUniversity Claude Bernard Lyon 1, Malaria Research Unit, SMITh, ICBMS, UMR 5246 CNRS-INSA-CPE-UCBL1, 8 avenue Rockefeller, 69373 Lyon cedex 08, France. ; Hospices Civils de Lyon, Institut de Parasitologie et de Mycologie Médicale (IP2M), Hôpital de la Croix-Rousse, 103 grande rue de la Croix-Rousse, 69317 Lyon cedex 04, France.
Stephane PicotUniversity Claude Bernard Lyon 1, Malaria Research Unit, SMITh, ICBMS, UMR 5246 CNRS-INSA-CPE-UCBL1, 8 avenue Rockefeller, 69373 Lyon cedex 08, France. ; Hospices Civils de Lyon, Institut de Parasitologie et de Mycologie Médicale (IP2M), Hôpital de la Croix-Rousse, 103 grande rue de la Croix-Rousse, 69317 Lyon cedex 04, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanisms of cell death in unicellular parasites have been subjects of debate for the last decade, with studies demonstrating evidence of apoptosis or non-apoptosis like mechanisms, including necrosis, and autophagy. Recent clarifications on the definition of regulated or accidental cell death by The Nomenclature Committee on Cell Death provides an opportunity to reanalyze some data, re-evaluate conclusions in the light of parasite diversity, and to propose alternative arguments in the context of malaria drug resistance, considering lack of really new drugs in the pipeline. Deciphering the mechanisms of death may help in detection of new drug targets and the design of innovative drugs. However, classifications have been evolving rapidly since initial description of "programmed cell death", leading to some uncertainty as to whether

Indexed as

apoptosisautophagycell deathmalariaPlasmodium

Identifiers

PMID28357297
PMCPMC5349169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.